key: cord-0802964-d7pkzyzc authors: Azzolino, Domenico; Cesari, Matteo title: Obesity and COVID-19 date: 2020-09-30 journal: Front Endocrinol (Lausanne) DOI: 10.3389/fendo.2020.581356 sha: e5fc38d85fcd3a7f8722ec3a8b237ecc6a50fff0 doc_id: 802964 cord_uid: d7pkzyzc nan 19 patients, visceral adiposity or high intramuscular fat deposition increases the risk for critical illness. The contribution of obesity to the severity of COVID-19 may be explained in multiple ways. Obesity is a well-recognized risk factor for diabetes, hypertension, and cardiovascular disease, all of which are predictors of poor outcomes in COVID-19 (12) . Obesity may also impair immune response to viral infections and affect diaphragm excursion (thus causing dysventilation) (3, 13) . Additionally, the management of obese patients with COVID-19 might be more challenging than routine because the patient's size may limit medical and assistive procedures. Furthermore, obesity is characterized by abnormal secretion of adipokines and cytokines determining a low-grade systemic inflammation, which may represent the background predisposition to the most severe consequences of COVID-19 (3) . At the same time, chronic low-grade inflammation represents a hallmark of aging, responsible for altered metabolism (i.e., elevation of resting energy expenditure) and increased muscle catabolism (14, 15) . Inflammation could be the key factor of the muscle decline observed in older individuals, which can be further exacerbated in those with obesity (16) . Obesity may also lead to increased fat infiltration of the muscle associated with a decrease in muscle strength and function, mainly due to physical inactivity of obese individuals. As a consequence, muscle decline may lead to a decrease in physical activity, which, in turn, promotes obesity with consequent increased catabolism and anabolic resistance, thus creating a vicious circle of muscle decline (17) . In fact, fat mass increase usually precedes a loss of muscle mass. In other words, the increase of adiposity (especially in visceral fat) along with the low-grade chronic inflammation seen with aging could have even more detrimental effects and determine an accelerated muscle decline. Interestingly, intermuscular adipose tissue is shown to contribute to physical impairment, enhancement of insulin resistance, and increased the risk of negative health-related events (18) . Additionally, an association between the SARS-CoV-2 infection and the angiotensin-converting enzyme 2 (ACE2) receptor is widely reported, potentially playing a critical role in the pathological pathway (19) (20) (21) . Interestingly, the expression of the ACE2 receptor is particularly present in adipose tissue (22, 23) , possibly explaining the higher susceptibility, greater severity, and worse prognosis for COVID-19 infection in obese patients (23, 24) . A controversy, however, exists about the protective or deleterious role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in COVID-19 (21) . In this global pandemic, the negative effects of obesity are not confined solely to the acute care setting. In fact, the need for social distancing and isolation during the lockdown may exacerbate depressive symptoms. Furthermore, self-isolation may increase the barriers to accessing healthy and fresh foods with a net shift toward convenience foods, especially in people with a poor socioeconomic status. The self-isolation period due to the lockdown may also lead to the deterioration of the circadian rhythm, resulting in a change of eating habits. Obesity has been widely related to sleep alteration and vice versa (25) . In fact, sleep disorders can result in metabolic (i.e., decreased glucose tolerance and insulin sensitivity) and endocrine alterations (i.e., reduced leptin levels, high evening concentrations of cortisol, ghrelin, and increased hunger and appetite), all of which promote obesity (26) . Sleep disturbances may also result from high circulating levels of pro-inflammatory cytokines, which are a hallmark of obesity (27) . Additionally, high-fat and high-carbohydrate meals may alter sleep indexes (26) (27) (28) (29) via the elevation of the circulating levels of glucose, insulin, leptin, cholecystokinin (CCK), peptide YY, and enterostatin (28) (29) (30) . On the other hand, it should not be neglected that obese individuals may suffer from stigma and depressive symptoms already in normal times. This may render them more likely to restrict their social contacts with detrimental consequences to their physical and psychological domains in the period of COVID-19 (31) . In conclusion, it is necessary that special attention is paid to prevent and control the COVID-19 infection in specific populations, such as obese and older persons, who are already exposed to basal inflammatory status. Inflammation, which is a hallmark of both obesity and the aging process, might have a synergistic role in promoting greater severity of COVID-19. However, as discussed, obesity measured with BMI does not necessarily reflect adiposity. Indeed, it is important to bear in mind that even though the box may look the same, the contents may be different. In this case, it would be better to think inside the box. The role of obesity in COVID-19, given the burden it poses, must no longer be ignored and may have major implications in the public health strategy. DA contributed to conceptualizing and writing the manuscript. MC edited and revised manuscript. DA and MC approved the final version of manuscript. All authors contributed to the article and approved the submitted version. Mild or Moderate Covid-19 Obesity and impaired metabolic health in patients with COVID-19 Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms Age-dependent relationships between body mass index and mortality: Singapore longitudinal ageing study ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection Protein metabolism and requirements in the ICU Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19 Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19 The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with Sars-COV-2 Endocrine and metabolic link to coronavirus infection Obesity could shift severe COVID-19 disease to younger ages The Role of Inflammation in Age-Related Sarcopenia The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure Health Consequences of Sarcopenic Obesity: A Narrative Review Sarcopenic obesity: definition, cause and consequences Intermuscular fat: a review of the consequences and causes Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients Two Things about COVID-19 Might Need Attention Obesity and sleep disturbances: Meaningful sub-typing of obesity Sleep and obesity Elevation of Plasma Cytokines in Disorders of Excessive Daytime Sleepiness: Role of Sleep Disturbance and Obesity Daytime Sleepiness in Obesity: Mechanisms Beyond Obstructive Sleep Apnea-A Review Effects of high-sugar and high-fiber meals on physical activity behaviors in Latino and African American adolescents: Dietary Sugar and Activity in Minority Adolescents Effects of Diet on Sleep Quality COVID 19 and the Patient with Obesity -The Editors Speak Out